Home - Prescription Medicines - Telmisartan and Amlodipine Tablets | Essential Hypertension | DengYueRX
Description
Indication & Scope
Telmisartan and Amlodipine Tablets is indicated for the treatment of essential hypertension in adult patients. It is specially applied to patients whose blood pressure cannot be effectively controlled by single-agent antihypertensive therapy with either telmisartan or amlodipine alone.
- Mechanism: Telmisartan selectively blocks angiotensin II type 1 receptors, inhibiting vasoconstriction and aldosterone secretion to reduce peripheral vascular resistance and lower blood pressure. Amlodipine is a calcium channel blocker that inhibits calcium ion influx into vascular smooth muscle cells, dilating peripheral arteries and reducing vascular resistance. The two ingredients exert synergistic antihypertensive effects through different pharmacological pathways.
- Drug class: Combination of Angiotensin II Receptor Blocker (ARB) and Dihydropyridine Calcium Channel Blocker (CCB).
- Clinical use: Clinically used for second-line antihypertensive treatment of essential hypertension. It simplifies medication regimens for patients with poor single-drug blood pressure control, improves medication adherence, and achieves stable long-term blood pressure regulation.
| Generic Name | Telmisartan and Amlodipine Tablets |
| Brand Name | – |
| Ingredient | Telmisartan and Amlodipine |
| Dosage Form | Tablets |
| Package | Telmisartan 80mg + Amlodipine besylate 5mg (calculated by C₂₀H₂₅ClN₂O₅) *7 tablets/box;
Telmisartan 40mg + Amlodipine besylate 5mg (calculated by C₂₀H₂₅ClN₂O₅) (quantity to be determined) |
| Conditions Treated | Essential hypertension |
| Taboos | Contraindicated in patients with severe hepatic impairment, severe renal dysfunction, and hypersensitivity to telmisartan, amlodipine or any excipients of the preparation. Contraindicated in pregnant women in the second and third trimesters |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Store at room temperature between 15°C and 30°C, keep dry, and protect from direct sunlight and moisture |
| Manufacturer | Sichuan Kelun Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20254641; H20254874 |
| Approval Date | Jun 24, 2025; Jul 15, 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: The dosage is individualized based on the patient’s blood pressure condition. The usual maintenance dose is one tablet taken once daily.
Time: Can be taken at any time of the day, with or without food, at a fixed daily time for consistent efficacy.
Instructions for use: Administer orally with a sufficient amount of water. Do not chew, crush or split the tablet. Strictly follow the fixed daily dosage without arbitrary dose increase or decrease.
Interaction: Concurrent use with potassium-sparing diuretics or potassium supplements may cause hyperkalemia. Combined use with non-steroidal anti-inflammatory drugs may increase renal function damage risk. Co-administration with other antihypertensive drugs may enhance hypotensive effects.
Side effects:
1. Common adverse reactions include dizziness, peripheral edema, fatigue, headache and flushing.
2. Rare adverse reactions include hypotension, gastrointestinal discomfort, muscle pain and abnormal liver function indicators.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What disease can Telmisartan and Amlodipine Tablets treat?
It is mainly used for the treatment of adult essential hypertension, especially for hypertension that cannot be well controlled by single antihypertensive medicine.
Is food intake required when taking Telmisartan and Amlodipine Tablets?
No food restriction is needed, and the tablet can be taken with or without meals.
What common discomfort may occur after taking Telmisartan and Amlodipine Tablets?
Mild dizziness, peripheral edema, fatigue and headache are the most common mild adverse reactions.
Who is prohibited from using Telmisartan and Amlodipine Tablets?
People with severe liver and kidney damage, hypersensitivity to drug ingredients, and pregnant women in the middle and late pregnancy are forbidden to use it.
Telmisartan and Amlodipine Tablets | Essential Hypertension | DengYueRX
INN: Telmisartan and Amlodipine Tablets
Indications: Essential hypertension
Dosage Form: Tablets
Strength: Telmisartan 80mg + Amlodipine besylate 5mg (calculated by C₂₀H₂₅ClN₂O₅) /tablet
$17.17 Original price was: $17.17.$14.59Current price is: $14.59.